Strategic approach to produce low-cost, efficient, and stable competitive internal controls for detection of RNA viruses by use of reverse transcription-PCR

Journal of Clinical Microbiology

Volumn 45, Issue 11, 2007, Pages 3555-3563

  Villanova, Gabriela V ^a,b   Gardiol, Daniela ^a,b   Taborda, Miguel A ^a   Reggiardo, Virginia ^c   Tanno, Hugo ^c   Rivadeneira, Emilia D ^d   Perez, Germán R ^a,b   Giri, Adriana A ^a,b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Consejo Nacional de Investigaciones Científicas Y Tecnológicas ^*  (Argentina)

^c Hospital Centenario de Rosario   (Argentina)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; HYDROCHLORIC ACID; MAGNESIUM SULFATE; RIBONUCLEASE; SODIUM CHLORIDE;

ARTICLE; BACTERIOPHAGE; BLOOD BANK; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; FREEZE DRYING; GENE TARGETING; HEPATITIS C VIRUS; HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA VIRUS; TECHNOLOGY; VIRUS DETECTION; VIRUS LOAD;

BASE SEQUENCE; COLIPHAGES; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 36348954523     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02601-06     Document Type: Article

References (35)

1. Asociación Argentina para el Estudio de las Enfermedades del Hígado. 2004. Consenso Argentino hepatitis C. Asociación Argentina para el Estudio de las Enfermedades del Hígado, Buenos Aires, Argentina. http://www.aaeeh.org.ar/conce2004.php.
2. Beld, M., R. Minnaar, J. Weel, C. Sol, M. Damen, H. van der Avoort, P. Wertheim-van Dillen, A. van Breda, and R. Boom. 2004. Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control. J. Clin. Microbiol. 42: 3059-3064.
3. Blackwell Publishing Ltd. 1999. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral Hepat. 6:35-47.
4. Chouhy, D., L. Benitez Gil, A. L. Nocito, D. Wojdyla, L. Ornella, J. Cittadini, D. Gardiol, and A. A. Giri. 2006. Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses. Int. J. Mol. Med. 18:995-1003.
5. Cleland, A., P. Nettleton, L. Jarvis, and P. Simmonds. 1999. Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang. 76:170-174.
6. Dingle, K. E., D. Crook, and K. Jeffery. 2004. Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR. J. Clin. Microbiol. 42:1003-1011.
7. Dreier, J., M. Störmer, and K. Kleesiek. 2005. Use of bacteriophage MS2 as an internal control in viral reverse transcription-PCR assays. J. Clin. Microbiol. 43:4551-4557.
8. Drosten, C., E. Seifried, and W. K. Roth. 2001. TaqMan 5′-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J. Clin. Microbiol. 39:4302-4308.
9. Eisler, D. L., A. McNabb, D. R. Jorgensen, and J. L. Isaac-Renton. 2004. Use of an internal positive control in a multiplex reverse transcription-PCR to detect West Nile virus RNA in mosquito pools. J. Clin. Microbiol. 42:841-343.
10. Gariglio, R., M. A. Taborda, R. Bortolozzi, J. L. McDermott, I. Martini, M. Borgognone, G. V. Villanova, O. E. Varnier, and A. A. Giri. 2004. Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA. Med. Buenos Aires 64:419-428.
11. Guichón, A., H. Chiparelli, A. Martinez, C. Rodriguez, A. Trento, J. C. Russi, and G. Carballal. 2004. Evaluation of a new NASBA assay for the qualitative detection of hepatitis C virus based on the NucliSens basic kit reagents. J. Clin. Virol. 29:84-91.
12. Gutfreund, K. S., and V. G. Bain. 2000. Chronic viral hepatitis C: management update. CMAJ 162:827-833.
13. Hazari, S., S. K. Acharya, and S. K. Panda. 2004. Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control. J. Virol. Methods 116:45-54.
14. Hietala, S. K., and B. M. Crossley. 2006. Armored RNA as virus surrogate in a real-time reverse transcriptase PCR assay proficiency panel. J. Clin. Microbiol. 44:67-70.
15. Jacobson, A. B., R. Arora, M. Zuker, C. Priano, C. H. Lin, and D. R. Mills. 1998. Structural plasticity in RNA and its role in the regulation of protein translation in coliphage Qβ. J. Mol. Biol. 275:589-600.
16. Katanaev, V. L., O. V. Kurnasov, and A. S. Spirin. 1995. Viral Qβ RNA as a high expression vector for mRNA translation in a cell-free system. FEBS Lett. 359:89-92.
17. Kleiboeker, S. B. 2003. Applications of competitor RNA in diagnostic reverse transcription-PCR. J. Clin. Microbiol. 41:2055-2061.
18. Klovins, J., V. Berzins, and J. van Duin. 1998. A long-range interaction in Qβ RNA that bridges the thousand nucleotides between the M-site and the 3′ end is required for replication. RNA 4:948-957.
19. McDermott, J. L., A. A. Giri, I. Martini, M. Bono, M. Giacomini, A. Campelli, L. Tagliaferro, A. Cara, and O. E. Varnier. 1999. Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy. J. Clin. Microbiol. 37:2361-2365.
20. Moradpour, D., A. Cerny, H. H. Markus, and E. H. Blum. 2001. Hepatitis C: an update. Swiss Med. Wkly. 131:291-298.
21. Mueller, J., M. Gessner, A. Remberg, J. Hoch, G. Zerlauth, and P. Hanfland. 2005. Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR assay with competitive internal control for the detection of hepatitis C virus RNA. Clin. Chem. Lab. Med. 43:827-833.
22. Mulder, J., N. McKinney, C. Chistopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
23. National Institutes of Health. 2002. NIH consensus statement on management of hepatitis C. NIH Consens. State Sci. Statements 19:1-46.
24. Niesters, H. G. M. 2004. Molecular and diagnostic clinical virology in real time. Clin. Microbiol. Infect. 10:5-11.
25. Pasloske, B. L., C. R. WalkerPeach, R. D. Obermoeller, M. Winkler, and D. B. DuBois. 1998. Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J. Clin. Microbiol. 36:3590-3594.
26. Quarleri, J. F., B. H. Robertson, V. L. Mathet, M. Feld, L. Espínola, M. P. Requeijo, O. Mandó, G. Carballal, and J. R. Oubiña. 2000. Genomic and phylogenetic analysis of hepatitis C virus isolates from Argentine patients: a 6-year retrospective study. J. Clin. Microbiol. 38:4560-4568.
27. Saldanha, J., N. Lelie, A. Heath, and the WHO Collaborative Study Group. 1999. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang. 76:149-158.
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Schuppli, D., I. Barrera, and H. Weber. 1994. Identification of recognition elements on bacteriophage Qβ minus strand RNA that are essential for template activity with Qβ replicase. J. Mol. Biol. 243:811-815.
30. Schwab, K. J., M. K. Estes, F. H. Neill, and R. L. Atmar. 1997. Use of heat release and internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J. Clin. Microbiol. 35:511-514.
31. Vasiljeva, I., T. M. Kozlovska, I. Cielens, A. K. Strelnikova, A. Kazaks, V. Ose, and P. Pumpens. 1998. Mosaic Qβ coats as a new presentation model. FEBS Lett. 431:7-11.
32. WalkerPeach, C. R., M. Winkler, D. B. DuBois, and B. L. Pasloske. 1999. Ribonuclease-resistant RNA controls (armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus. Clin. Chem. 45:2079-2085.
33. Wang, Q., K. Chang, M. G Han, S. Sreevatsan, and L. J. Saif. 2006. Development of a new microwell hybridization assay and an internal control RNA for the detection of porcine noroviruses and sapoviruses by reverse transcription-PCR. J. Virol. Methods 132:135-145.
34. Young, K. K. Y., R. M. Resnick, and T. W. Myers. 1993. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 31:882-886.
35. Young, K. K. Y., J. J. Archer, O. Yokosura, M. Omata, and R. M. Resnick. 1995. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J. Clin. Microbiol. 33:654-657.